US Archives - Page 80 of 185 - European Medical Journal

GLP-1 Drugs Linked to Lower Dementia and Stroke Risk

GLP-1 receptor agonists like semaglutide and tirzepatide are linked to significantly lower risks of dementia, ischemic stroke, and all-cause mortality in adults with type 2 diabetes and obesity, according to a large US cohort study.

Dual Vaccine Shows Strong Immune Response in Adults Over 50

A new multicomponent vaccine targeting both seasonal influenza and SARS-CoV-2 has demonstrated noninferior immunogenicity and acceptable safety in adults aged 50 years and older, according to results from a Phase III randomized trial.

New Imaging Index Forecasts Lymphoma Progression

A novel deep learning approach to body composition analysis may offer a cost-effective and clinically relevant method to predict treatment outcomes in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to findings from the LOTIS-2 trial.

How Menopause Alters Systemic Sclerosis Outcomes

Menopause status significantly shapes the clinical presentation of systemic sclerosis (SSc), according to new findings from a multicenter analysis of over 1,500 women enrolled in the SPRING-SIR registry.

More Infants Treated for Hemangiomas Post-Beta-Blocker Era

The use of beta-blockers has dramatically changed the management of infantile hemangiomas, with a significant increase in active treatment decisions at tertiary referral centers, according to a new retrospective cohort study.

Lack of Rigorous Clinical Data Risks Efficacy Decline in Influenza Vaccines

High-quality clinical data is essential to maintaining trust in influenza vaccination programs, especially as the global death toll from seasonal flu approaches 700,000 annually, disproportionately affecting older adults.

Global Psoriatic Arthritis Guidelines Reveal Gaps

A new comparative analysis of international guidelines for psoriatic arthritis (PsA) management reveals key divergences in treatment strategies across leading rheumatology societies, underscoring ongoing challenges in global consensus despite shared therapeutic goals.

New Mortality Risk Model for Severe Drug Reaction

A new international study has developed and validated prognostic models using novel inflammatory markers to predict in-hospital mortality in patients with drug reaction with eosinophilia and systemic symptoms (DRESS), a rare but life-threatening hypersensitivity reaction.

Is Faster Cancer Treatment Finally Within Reach? Understanding Subcutaneous Immunotherapy

Subcutaneous (SC) delivery of immunotherapies for solid tumors has emerged as a potentially transformative approach to cancer treatment, promising comparable clinical efficacy to intravenous (IV) therapies while significantly reducing treatment time and burden on healthcare systems.

Real-World Trial Validates AI for EGFR Mutation Testing in Lung Cancer

An artificial intelligence tool trained on digital pathology slides has demonstrated clinical-grade accuracy for detecting EGFR mutations in lung adenocarcinoma and significantly reduced reliance on molecular testing, according to results from a large-scale real-world deployment study.